Showing posts with label prevention. Show all posts
Showing posts with label prevention. Show all posts

Friday, February 8, 2013

New surgery helps prevent ovarian cancer


New surgery helps prevent ovarian cancer


KGW Staff
Posted on February 7, 2013 at 3:59 PM

PORTLAND, Oregon -- Doctors at a Portland hospital have joined some others across the nation and Canada in following a new recommendation aimed at preventing one of the deadliest forms of cancer in women.
“This is something so simple that could save a lot of lives,” said Dr. Nathalie Johnson, the Medical Director of the Legacy Cancer Institute. Johnson is recommending women who have tubal ligations or hysterectomies have their fallopian tubes removed.
"It’s because researchers have found the tubes attract cancer cells which can eventually encase the ovary," she said. "You could actually find a normal ovary wrapped in cancer and realize the cancer was starting in the fallopian tube and not the ovary."
The recommendation is supported by research on thousands of women. Legacy researcher Dr. Ann Smith-Shedev has studied the connection for more than a decade.
“We think this could cut the most common type of ovarian cancer by up to 70 percent,” Shedev said.
The Legacy Cancer Institute is the first program in Oregon to make the recommendation that women consider the fallopian tube removal if they’re scheduling a tubal ligation or hysterectomy.
“We’d like to raise awareness and hopefully it can become the standard here in Oregon and across the country,” said Johnson.


** I had several massive experimental surgeries in the early 1970's for lymphedema at Good Samaritan Hospital, which is now Legacy. My questions are, "is this really the answer?  Have you also warned your patients about the possibility of leg or abdominal lymphedema from such a surgery?"  Your peers in the 1960's at the Oregon Health Sciences University wrote a very interesting article about abdominal/leg lymphedema from an abdominal surgery. Pat**

Tuesday, December 25, 2012

BRCA testing impact on ovarian cancer prevention revealed


BRCA testing impact on ovarian cancer prevention revealed


Published on December 24, 2012 at 9:15 AM


By Lynda Williams, Senior medwireNews Reporter

Research shows that women without a confirmed BRCA mutation are choosing to undergo screening or surgery to prevent ovarian cancer, despite little evidence to support their use in this population.

After BRCA mutation testing and genetic counseling, a significant proportion of women with an uninformative result underwent risk-reducing salpingo-pophorectomy (RRSO; 12.3%), screening transvaginalultrasonography  (TVUS; 37.3%), or serum cancer  antigen (CA)-125 testing (33.8%).

"For most women with uninformative BRCA results, RRSO and ovarian cancer screening may not be appropriate, barring strong family histories of ovarian cancer," caution Gabriel Mannis (University of California, San Francisco, USA) and co-workers in the Archives of Internal Medicine.

The team followed up 1077 women for a median of 3.7 years after genetic counseling and BRCA testing. A positive BRCA test was confirmed in 18.7% of the patients, 9.6% had a true-negative result, and 71.8% had an uninformative test.
Compared with an uninformative result, a positive BRCA test strongly and significantly predicted the likelihood a woman would undergo RRSO (odds ratio [OR]=28.1), TVUS (OR=9.5), and serum cancer antigen (CA)-125 screening (OR=13.0).

This is in line with guidelines from the American College of Obstetricians and Gynecologists that recommend RRSO in BRCA-positive women aged over 40 years or after childbearing is complete, Mannis et al observe.

Conversely, a true-negative result was associated with a significantly reduced risk for RRSO (OR=0.1), TVUS (OR=0.2), and serum CA-125 screening (OR=0.3) compared with an uninformative test.

With a low 1-2% lifetime risk for ovarian cancer and the potential harm associated with false-positive test screening results, the team says these findings are in line with the knowledge that there is "insufficient evidence to recommend ovarian cancer screening for women with true-negative BRCA results."

Recognizing that the long-term risk for ovarian cancer in women with an uninformative BRCA test result is unknown, the researchers comment: "Because this population likely represents a heterogeneous group… it is possible that certain subgroups, such as women with strong family histories of ovarian cancer, may be at higher-than-average risk.
"In the face of such uncertainty, patients and physicians may opt to obtain screening tests despite the absence of evidence-based guidelines and the questionableefficacy. of these tests."